Vimarsana
Biggest News Aggregation in the World

Phil Preuss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phil Preuss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phil Preuss Today - Breaking & Trending Today

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity - Vimarsana News

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approx...

Avinger Reports First Quarter 2024 Results - Vimarsana News

Avinger Reports First Quarter 2024 Results

Advances New OCT-Guided Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / May 15, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, to...

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity - Vimarsana News

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

16.05.2024 - REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of ...

Avinger Reports Third Quarter 2023 Results - Vimarsana News

Avinger Reports Third Quarter 2023 Results

Avinger Reports Third Quarter 2023 Results

Avinger Reports Third Quarter 2023 Results - Vimarsana News

Avinger Reports Third Quarter 2023 Results

26.10.2023 - REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of ...